Biotest GmbH KGaA (LTS:0N6Z) Cash Flow for Dividends: £0.00 Mil (TTM As of . 20)


What is Biotest GmbH KGaA Cash Flow for Dividends?

Biotest GmbH KGaA LTS:0N6Z Cash Flow for Dividends is £0.00 Mil as of . 20.

Biotest GmbH KGaA's cash flow for dividends for the six months ended in . 20 was £0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Biotest GmbH KGaA Cash Flow for Dividends Related Terms

Biotest GmbH KGaA Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA Cash Flow for Dividends Chart

Biotest GmbH KGaA Annual Data
Trend
Cash Flow for Dividends

Biotest GmbH KGaA Semi-Annual Data
Cash Flow for Dividends

Biotest GmbH KGaA Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of £0.00 Mil mean?
Biotest GmbH KGaA (LTS:0N6Z) has a Cash Flow for Dividends of £0.00 Mil as of . 20. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Biotest GmbH KGaA and its competitors.
Is Biotest GmbH KGaA's Cash Flow for Dividends too high?
Biotest GmbH KGaA's current Cash Flow for Dividends is £0.00 Mil.
How does Biotest GmbH KGaA's Cash Flow for Dividends compare to ?
Biotest GmbH KGaA's Cash Flow for Dividends of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Biotest GmbH KGaA and its competitors. Biotest GmbH KGaA's current Cash Flow for Dividends is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest GmbH KGaA stock overvalued right now?
Biotest GmbH KGaA (LTS:0N6Z) has a current Cash Flow for Dividends of £0.00 Mil. The current Cash Flow for Dividends is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Biotest GmbH KGaA (LTS:0N6Z), the current Cash Flow for Dividends is £0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.